{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:22:50Z","timestamp":1793506970267,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA048172"],"award-info":[{"award-number":["K01DA048172"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA051777"],"award-info":[{"award-number":["K01DA051777"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30DA040500"],"award-info":[{"award-number":["P30DA040500"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01CE002999"],"award-info":[{"award-number":["R01CE002999"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA046527"],"award-info":[{"award-number":["R01DA046527"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000867","name":"Robert Wood Johnson Foundation","doi-asserted-by":"publisher","award":["RWJF77962"],"award-info":[{"award-number":["RWJF77962"]}],"id":[{"id":"10.13039\/100000867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001130","name":"Gerber Foundation","doi-asserted-by":"publisher","award":["GF192350"],"award-info":[{"award-number":["GF192350"]}],"id":[{"id":"10.13039\/100001130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jsat.2022.108800","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T09:12:05Z","timestamp":1652173925000},"page":"108800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder"],"prefix":"10.1016","volume":"140","author":[{"given":"Nadia","family":"Tabatabaeepour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake R.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi N.","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lica","family":"Meinhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jsat.2022.108800_bb0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Opioid use and opioid use disorder in pregnancy committee on obstetric practice american society of addiction medicine","volume":"130","year":"2017","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.jsat.2022.108800_bb0010","series-title":"State statutes search","author":"Administration for Children and Families","year":"2021"},{"issue":"6","key":"10.1016\/j.jsat.2022.108800_bb0015","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.whi.2016.09.002","article-title":"A moral or medical Problem? The relationship between legal penalties and treatment practices for opioid use disorders in pregnant females","volume":"26","author":"Angelotta","year":"2016","journal-title":"Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health"},{"issue":"1","key":"10.1016\/j.jsat.2022.108800_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1081\/ADA-120018838","article-title":"Effectiveness of substance abuse treatment programming for women: A review","volume":"29","author":"Ashley","year":"2003","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"5","key":"10.1016\/j.jsat.2022.108800_bb0025","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1377\/hlthaff.2019.00785","volume":"39","author":"Atkins","year":"2020","journal-title":"Health Affairs"},{"key":"10.1016\/j.jsat.2022.108800_bb0030","article-title":"The impact of state-level prenatal substance use policies on infant foster care entry in the United States","volume":"106194","author":"Atkins","year":"2021","journal-title":"Children and Youth Services Review"},{"issue":"9","key":"10.1016\/j.jsat.2022.108800_bb0035","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1377\/hlthaff.2021.00073","article-title":"The affordable care act increased medicaid coverage among former Foster youth: Study examines the affordable care act effect on medicaid coverage among former foster youth","volume":"40","author":"Bullinger","year":"2021","journal-title":"Health Affairs"},{"key":"10.1016\/j.jsat.2022.108800_bb0040","doi-asserted-by":"crossref","unstructured":"Cameron and Miller, n.d. A.C. Cameron D.L. Millern.d.A practitioner\u2019s guide to cluster-robust inference. Journal of Human Resources, 50(2):317\u2013372.","DOI":"10.3368\/jhr.50.2.317"},{"issue":"3","key":"10.1016\/j.jsat.2022.108800_bb0045","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1162\/rest.90.3.414","article-title":"Bootstrap-based improvements for inference with clustered errors","volume":"90","author":"Cameron","year":"2008","journal-title":"The Review of Economics and Statistics"},{"key":"10.1016\/j.jsat.2022.108800_bb0055","article-title":"Substance - exposed newborns: New federal law raises some old issues","author":"Christian","year":"2004","journal-title":"National Conference of State Legislatures, Children\u2019s Policy Initiative."},{"issue":"1","key":"10.1016\/j.jsat.2022.108800_bb0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1162\/REST_a_00049","article-title":"Inference with difference in differences with a small number of policy changes","volume":"93","author":"Conley","year":"2011","journal-title":"The Review of Economics and Statistics"},{"key":"10.1016\/j.jsat.2022.108800_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2102","article-title":"Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: Population based cohort study","volume":"350","author":"Desai","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jsat.2022.108800_bb0075","doi-asserted-by":"crossref","first-page":"B5","DOI":"10.1016\/j.ajog.2019.03.022","volume":"221","author":"Ecker","year":"2019","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"11","key":"10.1016\/j.jsat.2022.108800_bb0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.14078","article-title":"Association of punitive and reporting state policies related to substance use in pregnancy with rates of neonatal abstinence syndrome","volume":"2","author":"Faherty","year":"2019","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.jsat.2022.108800_bb0085","first-page":"163","article-title":"Postpartum treatment for substance use disorder among mothers of infants with neonatal abstinence syndrome and prenatal substance exposure","volume":"2","author":"Faherty","year":"2021","journal-title":"Females's Health reports (New Rochelle, N.Y.)"},{"issue":"5","key":"10.1016\/j.jsat.2022.108800_bb0095","first-page":"3","article-title":"Concerns mount over punitive approaches to substance abuse among pregnant females","volume":"1","author":"Figdor","year":"1998","journal-title":"The Guttmacher Report on Public Policy"},{"issue":"2","key":"10.1016\/j.jsat.2022.108800_bb0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1353\/hpu.2010.0174","article-title":"Women in residential drug treatment: Differences by program type and pregnancy","volume":"10","author":"Grella","year":"1999","journal-title":"Journal of Health Care for the Poor and Underserved"},{"key":"10.1016\/j.jsat.2022.108800_bb0120","series-title":"State policies on substance use during pregnancy","year":"2019"},{"issue":"2","key":"10.1016\/j.jsat.2022.108800_bb0125","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010\u20132017","volume":"325","author":"Hirai","year":"2021","journal-title":"Journal of the American Medical Association"},{"issue":"5","key":"10.1016\/j.jsat.2022.108800_bb0130","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1007\/s11606-020-06339-3","article-title":"Validity of incident opioid use disorder (OUD) diagnoses in administrative data: A chart verification study","volume":"36","author":"Howell","year":"2021","journal-title":"Journal of General Internal Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2022.108800_bb0135","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jsat.2011.02.004","article-title":"Long-term outcomes among drug-dependent mothers treated in women-only versus mixed-gender programs","volume":"41","author":"Hser","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2022.108800_bb0140","article-title":"Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: Cohort study","volume":"358","author":"Huybrechts","year":"2018","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.jsat.2022.108800_bb0145","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.whi.2016.12.008","article-title":"Characterization of us state laws requiring health care provider reporting of perinatal substance use","volume":"27","author":"Jarlenski","year":"2018","journal-title":"Females's Health Issues"},{"issue":"2","key":"10.1016\/j.jsat.2022.108800_bb0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/002204260303300202","article-title":"Extrinsic barriers to substance abuse treatment among pregnant drug dependent females","volume":"33","author":"Jessup","year":"2003","journal-title":"Journal of Drug Issues"},{"issue":"3","key":"10.1016\/j.jsat.2022.108800_bb0160","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.whi.2017.03.001","article-title":"Nonmedical use of prescription opioids among pregnant US women","volume":"27","author":"Kozhimannil","year":"2017","journal-title":"Women's Health Issues"},{"key":"10.1016\/j.jsat.2022.108800_bb0165","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.addbeh.2018.11.019","article-title":"Substance use disorder treatment admissions and state-level prenatal substance use policies: Evidence from a national treatment database","volume":"90","author":"Kozhimannil","year":"2019","journal-title":"Addictive Behaviors"},{"issue":"5","key":"10.1016\/j.jsat.2022.108800_bb0175","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1377\/hlthaff.2019.00814","article-title":"Neonatal abstinence syndrome in the United States, 2004\u201316: An examination of neonatal abstinence syndrome trends and incidence patterns across US census regions in the period 2004\u201316","volume":"39","author":"Leech","year":"2020","journal-title":"Health Affairs"},{"issue":"5","key":"10.1016\/j.jsat.2022.108800_bb1000","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1377\/hlthaff.2021.01755","article-title":"Prenatal Substance Use Policies And Infant Maltreatment Reports: Study examines prenatal substance use policies and infant maltreatment reports","volume":"41","author":"Maclean","year":"2022","journal-title":"Health Affairs"},{"issue":"6","key":"10.1016\/j.jsat.2022.108800_bb0185","first-page":"1158","article-title":"Opioid abuse and dependence during pregnancy: Temporal trends and obstetrical outcomes","volume":"121","author":"Maeda","year":"2014","journal-title":"The Journal of the American Society of Anesthesiologists"},{"issue":"1","key":"10.1016\/j.jsat.2022.108800_bb0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/pds.3284","article-title":"Algorithms to estimate the beginning of pregnancy in administrative databases","volume":"22","author":"Margulis","year":"2013","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"4","key":"10.1016\/j.jsat.2022.108800_bb0200","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1162\/ajhe_a_00101","article-title":"Prescription drug monitoring programs: The role of asymmetric information on drug availability and abuse","volume":"4","author":"Meinhofer","year":"2018","journal-title":"American Journal of Health Economics"},{"issue":"9","key":"10.1016\/j.jsat.2022.108800_bb0205","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamapediatrics.2019.1738","article-title":"Trends in foster care entry among children removed from their homes because of parental drug use, 2000 to 2018","volume":"173","author":"Meinhofer","year":"2019","journal-title":"JAMA Pediatrics"},{"key":"10.1016\/j.jsat.2022.108800_bb0210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jhealeco.2018.06.004","article-title":"The role of health insurance on treatment for opioid use disorders: Evidence from the affordable care act medicaid expansion","volume":"60","author":"Meinhofer","year":"2018","journal-title":"Journal of Health Economics"},{"key":"10.1016\/j.jsat.2022.108800_bb0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2019.12.005","article-title":"Substance use disorder treatment services for pregnant and postpartum women in residential and outpatient settings","volume":"110","author":"Meinhofer","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2022.108800_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhealeco.2021.102537","article-title":"Marijuana liberalization policies and perinatal health","volume":"80","author":"Meinhofer","year":"2021","journal-title":"Journal of Health Economics"},{"key":"10.1016\/j.jsat.2022.108800_bb2000","doi-asserted-by":"crossref","DOI":"10.1002\/hec.4518","article-title":"Prenatal substance use policies and newborn health","author":"Meinhofer","year":"2022","journal-title":"Health Economics"},{"key":"10.1016\/j.jsat.2022.108800_bb0225","article-title":"How states handle drug use during pregnancy","author":"Miranda","year":"2015","journal-title":"ProPublica."},{"key":"10.1016\/j.jsat.2022.108800_bb0230","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","article-title":"Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population","volume":"85","author":"Morgan","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2022.108800_bb0235","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2019.02.031","article-title":"Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort","volume":"200","author":"Morgan","year":"2019","journal-title":"Drug and alcohol dependence"},{"issue":"4","key":"10.1016\/j.jsat.2022.108800_bb0245","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/1475-6773.13125","article-title":"Will converting naloxone to over-the-counter status increase pharmacy sales?","volume":"54","author":"Murphy","year":"2019","journal-title":"Health Services Research"},{"key":"10.1016\/j.jsat.2022.108800_bb0250","article-title":"Factors associated with initial treatment choice, engagement, and discontinuation for patients with opioid use disorder","author":"Mutter","year":"2021","journal-title":"Psychiatric Services"},{"issue":"1","key":"10.1016\/j.jsat.2022.108800_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7517-9-14","article-title":"Integrated programs for mothers with substance abuse issues: A systematic review of studies reporting on parenting outcomes","volume":"9","author":"Niccols","year":"2012","journal-title":"Harm Reduction Journal"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2022.108800_bb0260","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1300\/J394v05n01_02","article-title":"Understanding and addressing racial\/ethnic disproportionality in the front end of the child welfare system","volume":"5","author":"Osterling","year":"2008","journal-title":"Journal of Evidence-Based Social Work"},{"issue":"18","key":"10.1016\/j.jsat.2022.108800_bb0270","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000\u20132009","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.jsat.2022.108800_bb0280","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13456","article-title":"Association of Pregnancy and Insurance Status with Treatment Access for opioid use disorder","volume":"3","author":"Patrick","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.jsat.2022.108800_bb0285","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/add.15650","article-title":"A response to \u201cAssociation between punitive policies and neonatal abstinence syndrome among medicaid-insured infants in complex policy environments\u201d","volume":"117","author":"Reddy","year":"2021","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.jsat.2022.108800_bb0295","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10995-010-0594-7","article-title":"Complex calculations: How drug use during pregnancy becomes a barrier to prenatal care","volume":"15","author":"Roberts","year":"2011","journal-title":"Maternal and Child Health Journal"},{"key":"10.1016\/j.jsat.2022.108800_bb0305","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.drugalcdep.2019.04.020","article-title":"Racial differences in the relationship between alcohol\/pregnancy policies and birth outcomes and prenatal care utilization: A legal epidemiology study","volume":"201","author":"Roberts","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2022.108800_bb0310","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1536867X19830877","article-title":"Fast and wild: Bootstrap inference in stata using boottest","volume":"19","author":"Roodman","year":"2015","journal-title":"The Stata Journal"},{"key":"10.1016\/j.jsat.2022.108800_bb0315","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.childyouth.2019.03.050","article-title":"Foster care admissions and state-level criminal justice-focused prenatal substance use policies","volume":"102","author":"Sanmartin","year":"2019","journal-title":"Children and Youth Services Review"},{"issue":"8","key":"10.1016\/j.jsat.2022.108800_bb0320","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jamapediatrics.2020.1027","article-title":"Association between state-level criminal justice-focused prenatal substance use policies in the US and substance use-related Foster Care admissions and family reunification","volume":"174","author":"Sanmartin","year":"2020","journal-title":"JAMA Pediatrics"},{"issue":"3","key":"10.1016\/j.jsat.2022.108800_bb0335","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/10522158.2017.1300113","article-title":"Substance abuse treatment engagement among mothers: Perceptions of the parenting role and agency-related motivators and inhibitors","volume":"20","author":"Seay","year":"2017","journal-title":"Journal of Family Social Work"},{"key":"10.1016\/j.jsat.2022.108800_bb0345","series-title":"National survey on drug use and health: 4-Year restricted online data system (2015 to 2018)","year":"2015"},{"issue":"4","key":"10.1016\/j.jsat.2022.108800_bb0360","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/0091450918790790","article-title":"Drug use during pregnancy policies in the United States from 1970 to 2016","volume":"45","author":"Thomas","year":"2018","journal-title":"Contemporary Drug Problems"},{"issue":"1","key":"10.1016\/j.jsat.2022.108800_bb0365","doi-asserted-by":"crossref","first-page":"83.e1","DOI":"10.1016\/j.ajog.2019.07.037","article-title":"Use of naltrexone in treating opioid use disorder in pregnancy","volume":"222","author":"Towers","year":"2020","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.jsat.2022.108800_bb0370","article-title":"Plan N: The case for over-the-counter naloxone","author":"Walsh","year":"2021","journal-title":"Health Affairs"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547222000824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547222000824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:57:48Z","timestamp":1760039868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547222000824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":56,"alternative-id":["S0740547222000824"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2022.108800","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2022.108800","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108800"}}